The 505(b)(2) regulatory pathway provides an attractive avenue for drug developers to bring new products to market by leveraging existing data on approved drugs. This pathway allows modifications and improvements to be made to existing drugs, while pot…
Leveraging 505(b)(2) to Innovate Beyond Existing Drug Patents Read Post »
In the high-stakes world of pharmaceuticals, patents play a pivotal role in safeguarding intellectual property and ensuring a return on investment for drug developers. The journey of a drug patent is a complex and intricate one, spanning from the initi…
The Intricate Journey of Drug Patents: From Filing to Expiry Read Post »
In the ever-evolving pharmaceutical landscape, savvy businesses are constantly on the lookout for untapped markets and lucrative opportunities. One area that has garnered significant attention is the realm of low-competition generic drugs. These are of…
Uncovering Lucrative Low-Competition Generic Drug Opportunities Read Post »
Branded generics are generic drugs that are marketed under a brand name by the manufacturer. These products contain the same active ingredients as their brand-name counterparts but are typically sold at a lower price point. Branded generics can be an a…
Maximizing ROI with Branded Generics: A Comprehensive Guide Read Post »
A recent whitepaper by Hermann Mucke summarizes the steps to performing an FTO for drug repurposing: Overview An FtO analysis determines if a new product or process can proceed without infringing third-party intellectual property (IP) rights, especiall…
A Practical Guide to FtO Analysis for Drug Repurposing Ventures Read Post »
The article “The devil is in the divisional: an analysis of divisional patents, deadlines, declarations and suggestions for future practice” by Mieke Filler provides a comprehensive analysis of the strategic use of divisional patents in the pharmaceuti…
Divisional Patent Minefields: Navigating Big Pharma’s Patent Extension Strategies Read Post »
Pharmaceutical companies employ various strategies to extend the commercial life and patent protection of successful drugs. Here are some key approaches with examples: New Formulations One common strategy is to develop and patent new formulations of th…
Innovative Approaches to Extend the Life of Drug Patents Read Post »
Sure, here’s a more detailed explanation with examples: Drug Patent Duration Drug patents are granted by the United States Patent and Trademark Office (USPTO) for a period of 20 years…
Source
In the “Patent Effect” podcast, Mustafa introduces his guest, Hakan Yum, the IP Director of Exrain Pharma, based in Sweden. The focus of the discussion is on patent litigation strategies…
Source
Crucial Insights on Patent Litigation Strategies in Pharma Industry Read Post »
In a recent study published in the Expert Review of Medical Devices, researchers investigated the utilization of patent term extensions (PTEs) to extend regulatory timeframes for medical devices in the…
Source
Underutilized Opportunities: Exploring Patent Term Extensions for Medical Devices Read Post »